CLDN5 and amyotrophic lateral sclerosis: In fact, C9-ALS iAstrocyte conditioned medium treatment caused an upregulation in the Glut-1 transporter in both control and C9-ALS BMEC-like cells; while it caused a decrease in Claudin-5 expression in ALS BMECs.